Glycomimetics Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 35 institutions reported holding Glycomimetics Inc. in their 13F filings, down 34 from Q1 2024. 3 opened new positions and 37 sold out. The largest holders were BVF Inc. ($2.7M), Artal Group S.A. ($2.4M) and Vanguard Group Inc. ($759K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Glycomimetics Inc.
- CUSIP
- 38000Q102
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $39K |
| Exits | 37 | $31.8M |
All 13F filers, Q1 2024 → Q2 2024: 1,227,826 shares bought and 12,516,702 shares sold, net −11,288,876 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| BVF Inc. | 0.08% | No change | 9,544,262 | $2.7M |
| Artal Group S.A. | 0.06% | No change | 8,589,064 | $2.4M |
| Vanguard Group Inc. | 0.00% | Reduce -2.4% | 2,696,906 | $759K |
| Renaissance Technologies | 0.00% | Add +483.5% | 826,851 | $233K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -27.8% | 804,342 | $227K |
| BlackRock Inc. | 0.00% | Reduce -1.3% | 723,184 | $204K |
| Acadian Asset Management LLC | 0.00% | Add +61.8% | 534,753 | $150K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.5% | 487,242 | $137K |
| Millennium Management | 0.00% | Reduce -75.1% | 186,227 | $52K |
| State Street Corp. | 0.00% | No change | 179,265 | $50K |
| ADAR1 Capital Management, LLC | 0.01% | New | 135,000 | $38K |
| Northern Trust Corp. | 0.00% | Reduce -0.8% | 127,792 | $36K |
| Two Sigma Advisers, LP | 0.00% | Add +271.3% | 108,800 | $31K |
| Sargent Investment Group, LLC | 0.01% | Reduce -7.4% | 100,000 | $28K |
| UBS Group AG | 0.00% | Add +5434.7% | 83,020 | $23K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -51.5% | 81,800 | $23K |
| Group One Trading LLC | 0.00% | Add +128.2% | 65,433 | $18K |
| HRT Financial LP | 0.00% | Reduce -69.4% | 47,683 | $13K |
| Intellectus Partners, LLC | 0.00% | Reduce -9.4% | 45,965 | $13K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 45,250 | $13K |
| Ieq Capital, LLC | 0.00% | No change | 38,363 | $11K |
| Jane Street Group, LLC | 0.00% | Reduce -89.7% | 29,697 | $8K |
| LPL Financial LLC | 0.00% | Reduce -50.0% | 29,000 | $8K |
| Tobias Financial Advisors, Inc. | 0.00% | No change | 15,000 | $4K |
| LMR Partners LLP | 0.00% | No change | 14,102 | $4K |
| Bank of America Corp. | 0.00% | Reduce -89.4% | 5,402 | $2K |
| Morgan Stanley | 0.00% | Reduce -95.0% | 5,176 | $1K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 4,755 | $1K |
| Royal Bank of Canada | 0.00% | Add +15.9% | 2,319 | $1K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -99.5% | 1,101 | $310 |
| Rhumbline Advisers | 0.00% | No change | 1,044 | $294 |
| National Bank of Canada | 0.00% | New | 600 | $177 |
| BNP Paribas Financial Markets | 0.00% | No change | 481 | $135 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.8% | 151 | $43 |
| Barclays PLC | 0.00% | No change | 76 | $21 |
"% of holder's portfolio" is GLYCOMIMETICS INC's weight in each manager's 13F, not the share of Glycomimetics Inc. the manager owns.